跳至主要内容
临床试验/NCT06328790
NCT06328790招募中不适用

A Window Into the Mind-brain-body Interplay: Development of Diagnostic, Prognostic Biomarkers and Rehabilitation Strategies in Functional Motor Disorders

Michele Tinazzi, MD, PhD3 个研究点 分布在 1 个国家目标入组 450 人开始时间: 2023年5月31日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
450
试验地点
3
主要终点
Simplified Functional Movement Disorders Rating Scale (S-FMDRS) score

研究概览

简要总结

Functional motor disorders (FMD) are prevalent and highly disabling conditions characterized by abnormal movements (functional weakness, tremor, dystonia) significantly altered by distractive manoeuvres and incongruent with movement disorders seen in specific neurological diseases. FMDs are still misunderstood, diagnosed with delay, and not adequately treated, leading to reduced independence and high healthcare costs. Symptoms are physiologically associated with voluntary movement (distractibility, resolution with placebo) but are reported as involuntary. How this happens is yet a matter of debate. Identifying diagnostic and prognostic disease-specific biomarkers is an unmet need. The investigators will investigate motor, exteroceptive and interoceptive domains in a large cohort of FMD patients by a comprehensive set of behavioural, neurophysiological, and MRI tests. Ad-hoc eXplainable Artificial Intelligence (XAI) methods will develop disease-specific diagnostic and prognostic biomarker algorithms.

详细描述

Functional motor disorders (FMD) are part of the broad spectrum of functional neurological disorders characterized by abnormal movements (functional limb weakness, tremor, dystonia) significantly altered by distractive manoeuvres and incongruent with movement disorders seen in specific neurological diseases. FMDs have a high prevalence, are still misunderstood, diagnosed with a long delay, and not adequately treated, leading to high degrees of disability and poor quality of life with increasing social and economic costs. The old concept of psychological factors as the primary cause (conversion disorder) has been abandoned due to the lack of evidence about their causal role. According to a predictive coding account, the emerging idea is that symptoms and disability in FMD may depend on dysfunctions of a specific neural system integrating interoception, exteroception, and motor control. The idea underpins the investigator's proposal that FMD symptoms are perceptions of the state of the body. Besides the main pathophysiological features (abnormal attentional focus, beliefs/expectations, and sense of agency), the lived experience of symptoms and their resulting disability may depend on a specific neural system integrating motor, exteroceptive and interoceptive domains. Therefore, dysfunction within this system can cause and sustain motor and non-motor symptoms in FMD. Three-stage research will be conducted. A large cohort of patients with a definite diagnosis of FMD (n=150) and healthy controls (n=150) will be investigated by behavioural, neurophysiological, and MRI tests to collect biomarkers in the motor, exteroceptive and interoceptive domains. Computational modelling of the behavioural, neurophysiological, and MRI biomarkers will be developed through eXplainable Artificial Intelligence (XAI) methods through a data mining approach (machine learning) to implement a diagnostic algorithm biomarker (objective 1). A cohort of patients with "organic" motor disorders (n=75) will undergo the same behavioural, neurophysiological, and MRI tests belonging to the resulting biomarker-based diagnostic algorithm for validation (objective 2). Finally, the modulation of the resulting biomarker-based diagnostic algorithm after rehabilitation and the correlations of motor and non-motor symptoms (NMSs) with clinical improvement will be investigated in a sub-group of patients with FMD to explore the predictive value (objective 3). Our proposal consists of 6 work packages (WP), all integrated to deliver our stated objectives over the project's lifetime to achieve these objectives. Communication and dissemination activities will include the project's visual identity, public website, social media, videos, and press releases. Our proposal will inform the research and clinical community on disease-specific biomarkers for diagnosing and prognosis patients with FMD. The proposed approach has significant potential to disentangle some of the poorly understood features of these disorders, potentially providing a platform for more fundamental insights into brain functioning and the development of precision medicine approaches in their management. The proposed approach can also give the clinicians validated examinations to make a correct early diagnosis. This will improve the management of FMD with a positive impact on the patient's disability and the socio-economic costs of the illness.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Simplified Functional Movement Disorders Rating Scale (S-FMDRS) score

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

Objective-rated validated scale to rate the duration and severity of functional motor symptoms (range: 0-54; higher = worse).

Beck Anxiety Inventory (BAI) score

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

It evaluates anxiety (range: 0-63; higher = worse).

12-item Short-Form Health Survey (SF-12) score

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

The health-Related QoL will be evaluated by the Mental Health and Physical functioning of the 12-item Short-Form Health Survey (SF-12) (range: 0-100; higher = better).

Toronto Alexithymia Scale (TAS-20) score

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

It evaluates the level of alexithymia (range: 20-100; higher = worse).

N2/P2 amplitude

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

Laser evoked potentials (LEP) will be used to collect data

Cortical thickness and gray matter volumes

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

Brain 3 Tesla MRI will be used to collect data

Swing time (%)

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

Gait analysis will be used to collect swing time (%).

Brief Pain Inventory (BPI) score

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

It evaluates pain intensity (range: 0-40; higher = worse) and interference (range: 0-70; higher = worse).

Multidimensional Fatigue Inventory Scale (MFI-20) score

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

It evaluates fatigue differentiating general, physical, reduced-activity, reduced-motivation, and mental fatigue (subscale range: 4-20; higher = worse).

Joint angle at the elbow vibrated and reproduced

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

Tonic vibration reflex (TVR) will be used to collect data

Direct adn indirect index of Sensory Attenuation (SA)

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

Sensory attenuation (SA) will be used to collect data

Clinical Global Impression (CGI) score

时间窗: After 3 months of the intensive 5-day rehabilitation protocol (T1).

Self-rated perception of change will be assessed with the 7-point Clinical Global Impression (CGI) scale with scores from 1 (very much improved) to 7 (very much worse).

Gait speed (cm/sec)

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

Gait analysis will be used to collect gait speed (cm/s).

Velocity of Cop displacement in the mediolateral directions (mm/s)

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

An electronic monaxial stabilometric platform will be used to collect the velocity of Cop displacement in the mediolateral directions.

Beck Depression Inventory (BDI-II) score

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

It evaluates depression (range: 0-63; higher = worse).

Stance time (sec)

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

An electronic monaxial stabilometric platform will be used to collect stance time (sec).

Velocity of Cop displacement in the anteroposterior directions (mm/s)

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

An electronic monaxial stabilometric platform will be used to collect the velocity of Cop displacement in the anteroposterior directions.

Autism spectrum Quotient (AQ)

时间窗: Before the intensive 5-day rehabilitation protocol (T0)

It is a 50-item self-report measure used to assess traits of autism in adults and adolescents aged 16 years and over (Total score: 0-50; cut-off: \> 29).

Objective/Subjective heart rate ratio

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

Heartbeat Perception Task (HPT) will be used to collect data

Stride time (s)

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

Gait analysis will be used to collect stride time (s).

Sway area (mm2)

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

An electronic monaxial stabilometric platform will be used to collect sway area (mm2).

Schizotypal Personality Questionnaire (SPQ)

时间窗: Before the intensive 5-day rehabilitation protocol (T0)

It is a scale for the assessment of schizotypal personality based on DSM-III-R criteria (Total score: 0-74; cut-off: \< 8 \& \> 42).

Stride length (cm)

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

Gait analysis will be used to collect stride length (cm).

Total excursion path (mm)

时间窗: Before the intensive 5-day rehabilitation protocol (T0) and after 3 months of the intensive 5-day rehabilitation protocol (T1).

An electronic monaxial stabilometric platform will be used to collect total excursion path (mm): area of oscillations of the Center of Pressure (CoP), CoP perimeter length

次要结局

未报告次要终点

研究者

发起方
Michele Tinazzi, MD, PhD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Michele Tinazzi, MD, PhD

Principal Investigator

Universita di Verona

研究点 (3)

Loading locations...

相似试验

Study of Biomorkers and Rehabilitation Strategies in... | 临床试验